Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1794 1
1845 1
1850 3
1851 1
1853 1
1875 1
1886 1
1888 1
1889 1
1891 2
1892 1
1893 5
1895 1
1896 2
1897 1
1899 6
1900 1
1901 2
1902 2
1903 2
1904 1
1905 1
1906 1
1907 3
1908 8
1909 3
1910 6
1924 2
1932 1
1933 1
1936 2
1937 2
1939 3
1941 1
1945 4
1946 5
1947 4
1948 5
1949 1
1950 5
1951 4
1952 3
1953 8
1954 5
1955 5
1956 6
1957 8
1958 5
1959 8
1960 7
1961 14
1962 10
1963 15
1964 8
1965 8
1966 11
1967 19
1968 14
1969 24
1970 19
1971 36
1972 23
1973 22
1974 32
1975 27
1976 39
1977 23
1978 38
1979 47
1980 51
1981 61
1982 64
1983 69
1984 73
1985 51
1986 75
1987 89
1988 108
1989 101
1990 101
1991 99
1992 90
1993 77
1994 93
1995 95
1996 100
1997 96
1998 90
1999 92
2000 98
2001 120
2002 126
2003 144
2004 125
2005 142
2006 149
2007 136
2008 170
2009 156
2010 158
2011 187
2012 194
2013 193
2014 201
2015 228
2016 206
2017 218
2018 234
2019 216
2020 234
2021 228
2022 198
2023 193
2024 67

Text availability

Article attribute

Article type

Publication date

Search Results

6,113 results

Results by year

Filters applied: . Clear all
Page 1
CD8+ T cell-intrinsic IL-6 signaling promotes resistance to anti-PD-L1 immunotherapy.
Huseni MA, Wang L, Klementowicz JE, Yuen K, Breart B, Orr C, Liu LF, Li Y, Gupta V, Li C, Rishipathak D, Peng J, Şenbabaoǧlu Y, Modrusan Z, Keerthivasan S, Madireddi S, Chen YJ, Fraser EJ, Leng N, Hamidi H, Koeppen H, Ziai J, Hashimoto K, Fassò M, Williams P, McDermott DF, Rosenberg JE, Powles T, Emens LA, Hegde PS, Mellman I, Turley SJ, Wilson MS, Mariathasan S, Molinero L, Merchant M, West NR. Huseni MA, et al. Among authors: williams p. Cell Rep Med. 2023 Jan 17;4(1):100878. doi: 10.1016/j.xcrm.2022.100878. Epub 2023 Jan 3. Cell Rep Med. 2023. PMID: 36599350 Free PMC article.
Cryo-EM diversifies.
Lea SM, Williams PA. Lea SM, et al. Among authors: williams pa. Curr Opin Struct Biol. 2022 Dec;77:102469. doi: 10.1016/j.sbi.2022.102469. Epub 2022 Sep 29. Curr Opin Struct Biol. 2022. PMID: 36183448 No abstract available.
1930s techniques.
Williams PR. Williams PR. Br Dent J. 2021 May;230(10):624. doi: 10.1038/s41415-021-3098-5. Br Dent J. 2021. PMID: 34050272 No abstract available.
Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trial.
Powles T, Yuen KC, Gillessen S, Kadel EE 3rd, Rathkopf D, Matsubara N, Drake CG, Fizazi K, Piulats JM, Wysocki PJ, Buchschacher GL Jr, Alekseev B, Mellado B, Karaszewska B, Doss JF, Rasuo G, Datye A, Mariathasan S, Williams P, Sweeney CJ. Powles T, et al. Among authors: williams p. Nat Med. 2022 Jan;28(1):144-153. doi: 10.1038/s41591-021-01600-6. Epub 2022 Jan 10. Nat Med. 2022. PMID: 35013615 Free PMC article. Clinical Trial.
Tazemetostat for tumors harboring SMARCB1/SMARCA4 or EZH2 alterations: results from NCI-COG pediatric MATCH APEC1621C.
Chi SN, Yi JS, Williams PM, Roy-Chowdhuri S, Patton DR, Coffey BD, Reid JM, Piao J, Saguilig L, Alonzo TA, Berg SL, Ramirez NC, Jaju A, Mhlanga JC, Fox E, Hawkins DS, Mooney MM, Takebe N, Tricoli JV, Janeway KA, Seibel NL, Parsons DW. Chi SN, et al. Among authors: williams pm. J Natl Cancer Inst. 2023 Nov 8;115(11):1355-1363. doi: 10.1093/jnci/djad085. J Natl Cancer Inst. 2023. PMID: 37228094
Osteitis Condensans Ilii.
Williams PM, Byerly DW. Williams PM, et al. 2023 May 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. 2023 May 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 31855396 Free Books & Documents.
The NCI-MATCH trial: lessons for precision oncology.
O'Dwyer PJ, Gray RJ, Flaherty KT, Chen AP, Li S, Wang V, McShane LM, Patton DR, Tricoli JV, Williams PM, Iafrate AJ, Sklar J, Mitchell EP, Takebe N, Sims DJ, Coffey B, Fu T, Routbort M, Rubinstein LV, Little RF, Arteaga CL, Marinucci D, Hamilton SR, Conley BA, Harris LN, Doroshow JH. O'Dwyer PJ, et al. Among authors: williams pm. Nat Med. 2023 Jun;29(6):1349-1357. doi: 10.1038/s41591-023-02379-4. Epub 2023 Jun 15. Nat Med. 2023. PMID: 37322121 Review.
Repeated intravenous cardiosphere-derived cell therapy in late-stage Duchenne muscular dystrophy (HOPE-2): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
McDonald CM, Marbán E, Hendrix S, Hogan N, Ruckdeschel Smith R, Eagle M, Finkel RS, Tian C, Janas J, Harmelink MM, Varadhachary AS, Taylor MD, Hor KN, Mayer OH, Henricson EK, Furlong P, Ascheim DD, Rogy S, Williams P, Marbán L; HOPE-2 Study Group. McDonald CM, et al. Among authors: williams p. Lancet. 2022 Mar 12;399(10329):1049-1058. doi: 10.1016/S0140-6736(22)00012-5. Lancet. 2022. PMID: 35279258 Free article. Clinical Trial.
6,113 results